Adverse Drug Reactions
Neurogen Proprietary Insomnia Compound Data for Two Studies Presented at Associated Professional Sleep Societies Annual Meeting
Published in Telemedicine Business Week, July 4th, 2007
Neurogen Corporation (Nasdaq: NRGN) today announced that data from previous Phase 1 and Phase 2a clinical studies for NG2-73, the Company's lead compound for the treatment of insomnia, were presented in two sessions at the SLEEP 2007 Annual Meeting of the Associated Professional Sleep Societies (APSS) in Minneapolis, Minnesota. Two Phase 2b clinical studies with NG2-73 in chronic insomnia patients are currently being conducted by the Company. Data presented at the APSS meeting today includes the following: "Effects of NG2-73 on Sleep Onset, Quality and Next Day Function in a Transient Insomnia Study" (Phase 2a) NG2-73 is a partial agonist with preference for GABA(A) receptors containing...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week
More Articles from Telemedicine Business Week
- Abdominal Pain
Findings in abdominal pain in children reported from University of Pennsylvania - Abscess
Findings in abscess reported from Juntendo University, Department of Gastroenterology - Adenoid Cystic Cancer
Researchers from University of Texas, M. D. Anderson Cancer Center publish new studies and findings in the area of adenoid cystic cancer - Adenoma
Data from Jagiellonian University, College of Medicine advance knowledge in adenoma - Agammaglobulinemia Immunology
Turku University, Department of Pediatrics publishes research in agammaglobulinemia immunology - Agilent Technologies Inc.
Agilent Technologies Expands Informatics Portfolio with Electronic Notebook for Life Sciences, Chemical Analysis After Acquiring Kalabie from Klee Group - More from this issue of Telemedicine Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
